» Articles » PMID: 35806455

Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations

Abstract

Brain stroke is a highly prevalent pathology and a main cause of disability among older adults. If not promptly treated with recanalization therapies, primary and secondary mechanisms of injury contribute to an increase in the lesion, enhancing neurological deficits. Targeting excitotoxicity and oxidative stress are very promising approaches, but only a few compounds have reached the clinic with relatively good positive outcomes. The exploration of novel targets might overcome the lack of clinical translation of previous efficient preclinical neuroprotective treatments. In this study, we examined the neuroprotective properties of 2-aminoethoxydiphenyl borate (2-APB), a molecule that interferes with intracellular calcium dynamics by the antagonization of several channels and receptors. In a permanent model of cerebral ischemia, we showed that 2-APB reduces the extent of the damage and preserves the functionality of the cortical territory, as evaluated by somatosensory evoked potentials (SSEPs). While in this permanent ischemia model, the neuroprotective effect exerted by the antioxidant scavenger cholesteronitrone F2 was associated with a reduction in reactive oxygen species (ROS) and better neuronal survival in the penumbra, 2-APB did not modify the inflammatory response or decrease the content of ROS and was mostly associated with a shortening of peri-infarct depolarizations, which translated into better cerebral blood perfusion in the penumbra. Our study highlights the potential of 2-APB to target spreading depolarization events and their associated inverse hemodynamic changes, which mainly contribute to extension of the area of lesion in cerebrovascular pathologies.

Citing Articles

Mefloquine-induced conformational shift in Cx36 N-terminal helix leading to channel closure mediated by lipid bilayer.

Cho H, Chung D, Lee H Nat Commun. 2024; 15(1):9223.

PMID: 39455592 PMC: 11512059. DOI: 10.1038/s41467-024-53587-6.


Impact of Mobile Health Literacy, Stroke-Related Health Knowledge, Health Beliefs, and Self-Efficacy on the Self-Care Behavior of Patients with Stroke.

Kim H, Han A, Lee H, Choi J, Lee H, Cho M Healthcare (Basel). 2024; 12(19).

PMID: 39408093 PMC: 11476478. DOI: 10.3390/healthcare12191913.


Permselectivity of Silk Fibroin Hydrogels for Advanced Drug Delivery Neurotherapies.

Fernandez-Serra R, Lekouaghet A, Peracho L, Yonesi M, Alcazar A, Chioua M Biomacromolecules. 2024; 25(8):5233-5250.

PMID: 39018332 PMC: 11323009. DOI: 10.1021/acs.biomac.4c00629.


The Prognostic Significance of Early Glycemic Profile in Acute Ischemic Stroke Depends on Stroke Subtype.

Forti P, Maioli F J Clin Med. 2023; 12(5).

PMID: 36902581 PMC: 10003561. DOI: 10.3390/jcm12051794.


Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models.

Chamorro B, Izquierdo-Bermejo S, Serrano J, Hadjipavlou-Litina D, Chioua M, Lopez-Munoz F Sci Rep. 2023; 13(1):2865.

PMID: 36805655 PMC: 9938201. DOI: 10.1038/s41598-023-29929-7.


References
1.
Brennan K, Romero Reyes M, Lopez Valdes H, Arnold A, Charles A . Reduced threshold for cortical spreading depression in female mice. Ann Neurol. 2007; 61(6):603-6. DOI: 10.1002/ana.21138. View

2.
Lee C, Folsom A, Blair S . Physical activity and stroke risk: a meta-analysis. Stroke. 2003; 34(10):2475-81. DOI: 10.1161/01.STR.0000091843.02517.9D. View

3.
Eroglu E, Unel C, Harmanci N, Erol K, Ari N, Ozatik O . 2-Aminoethoxydiphenyl borate ameliorates functional and structural abnormalities in cisplatin-induced peripheral neuropathy. J Trace Elem Med Biol. 2021; 70:126909. DOI: 10.1016/j.jtemb.2021.126909. View

4.
Dreier J . The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011; 17(4):439-47. DOI: 10.1038/nm.2333. View

5.
Gallanagh S, Quinn T, Alexander J, Walters M . Physical activity in the prevention and treatment of stroke. ISRN Neurol. 2012; 2011:953818. PMC: 3263535. DOI: 10.5402/2011/953818. View